- Trials with a EudraCT protocol (149)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
149 result(s) found for: Atrium.
Displaying page 1 of 8.
EudraCT Number: 2005-000715-98 | Sponsor Protocol Number: EFC5555 | Start Date*: 2005-12-28 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: A placebo-controlled, double blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with... | |||||||||||||
Medical condition: atrial fibrillation/atrial flutter | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) SE (Completed) FI (Completed) CZ (Completed) BE (Completed) NO (Completed) IT (Completed) PT (Completed) DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000823-40 | Sponsor Protocol Number: DRI5760 | Start Date*: 2005-08-01 | |||||||||||
Sponsor Name:Sanofi-Synthelabo-Recherche | |||||||||||||
Full Title: Double blind placebo controlled dose ranging study of the efficacy and safety of SSR149744C 300 or 600 mg for the conversion of atrial fibrillation/flutter | |||||||||||||
Medical condition: Atrial fibrillation/flutter | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) PT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023020-24 | Sponsor Protocol Number: 12579 | Start Date*: 2010-11-24 | |||||||||||
Sponsor Name:Helsinki University Central Hospital | |||||||||||||
Full Title: Dexmedetomidin compared with placebo in sedation during radiofrequency catheter ablation of atrial fibrillation | |||||||||||||
Medical condition: Sedation level between dexmedetomidin and placebo during radiofrequency catheter ablation of atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003036-53 | Sponsor Protocol Number: G 106 | Start Date*: 2004-10-26 | |||||||||||
Sponsor Name:A. N. M. C. O. - FONDAZIONE ITALIANA LOTTA MALATTIE CARDIOVASCOLARI | |||||||||||||
Full Title: GISSI AF Randomized, prospective, parallel group, placebo-controlled, multi-center study on the use of valsartan an angiotensin II AT1-receptor blocker in the prevention of Atrial Fibrillation rec... | |||||||||||||
Medical condition: Atrial Fibrillation Prevention | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004969-41 | Sponsor Protocol Number: SPA-S-891/051 | Start Date*: 2006-02-14 | |||||||||||
Sponsor Name:SOCIETA PRODOTTI ANTIBIOTICI | |||||||||||||
Full Title: A double-blind, controlled vs placebo trial to evaluate the efficacy of EPA and DHA ethyl esters, in addition to usual antiarrhythmic therapy, in the manintenance of synus rythm in patients candida... | |||||||||||||
Medical condition: Patients with persistent atrial fibrillation candidated to electrical cardioversion. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004918-40 | Sponsor Protocol Number: | Start Date*: 2006-10-06 | |||||||||||
Sponsor Name:KYS | |||||||||||||
Full Title: Intravenöösi metoproli versus amiodaroni sydänleikkauksen jälkeisen eteisvärinän estossa: vertaileva tutkimus tehosta, sivuvaikutuksista ja kustannuksista | |||||||||||||
Medical condition: MCC, lusuff.valv. aortae, stenosis valv. aortae | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006932-36 | Sponsor Protocol Number: 2505 | Start Date*: 2009-01-16 | |||||||||||
Sponsor Name:Martin Maaroos | |||||||||||||
Full Title: Comparison of biatrial pacing an intravenous metoprolol infusion in prediction of postoperative atrial fibrillation after coronary artery bypass grafting | |||||||||||||
Medical condition: research individuals have passed coronary artery bypass grafting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020782-24 | Sponsor Protocol Number: 12578 | Start Date*: 2010-11-24 | |||||||||||
Sponsor Name:Helsinki University Central Hospital | |||||||||||||
Full Title: The effects of dexmedetomidine on cardiac electrophysiology in adults | |||||||||||||
Medical condition: Myocardial electrophysiology of the patients with paroxysmal atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-018215-53 | Sponsor Protocol Number: AFRODITE | Start Date*: 2010-02-10 | ||||||||||||||||
Sponsor Name:sanofi-aventis Netherlands | ||||||||||||||||||
Full Title: The effect of the addition of dronedarone to, versus increase of, existing conventional rate control medication on ventricular rate during paroxysmal or persistent atrial fibrillation (AFRODITE study) | ||||||||||||||||||
Medical condition: atrial fibrillation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002755-94 | Sponsor Protocol Number: CV185-391 | Start Date*: 2016-07-26 | |||||||||||
Sponsor Name:FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE | |||||||||||||
Full Title: MicroRNAs and target genes modulation in subjects with atrial fibrillation treated with apixaban or warfarin | |||||||||||||
Medical condition: Atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005804-15 | Sponsor Protocol Number: EFC4968 | Start Date*: 2007-04-11 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: Randomized double blind trial to evaluate the efficacy and safety of dronedarone (400 mg BID) versus amiodarone (600 mg daily for 28 days then 200 mg daily thereafter) for at least 6 months for the... | |||||||||||||
Medical condition: Atrial Fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) SE (Completed) BE (Completed) FI (Completed) EE (Completed) AT (Completed) IT (Completed) NL (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000442-18 | Sponsor Protocol Number: ABM/2020/1/00002 | Start Date*: 2021-09-24 | ||||||||||||||||
Sponsor Name:National Institute of Cardiology | ||||||||||||||||||
Full Title: Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial) | ||||||||||||||||||
Medical condition: Mitral regurgitation Atrial fibrilation Periprocedural anticoagulation strategy in patients treated with MitraClip implantation or Left Atrial Appendage Closure. The patients scheduled for Mitr... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005248-17 | Sponsor Protocol Number: 1160.71 | Start Date*: 2008-11-20 | |||||||||||
Sponsor Name:Boehringer Ingelheim AB | |||||||||||||
Full Title: RELY-ABLE long term multi-center extension of dabigatran treatment in patients with atrial fibrillation who completed the RE-LY trial and a cluster randomised trial to assess the effect of a knowle... | |||||||||||||
Medical condition: This is a study of the long term safety of dabigatran (intended indication: stroke prevention in patients with atrial fibrillation).Eligible patients received dabigatran during the RE-LY trial 1160... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) NL (Completed) FI (Completed) DE (Completed) DK (Completed) AT (Completed) GB (Completed) SK (Completed) FR (Completed) BE (Completed) HU (Completed) PL (Completed) CZ (Completed) IT (Completed) PT (Completed) BG (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000530-29 | Sponsor Protocol Number: CONVERT-AF | Start Date*: 2014-08-19 | |||||||||||
Sponsor Name:University Hospital Basel | |||||||||||||
Full Title: Canakinumab for the Prevention of Recurrences After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation (CONVERT-AF) Trial - A Randomized Double Blind Placebo Controlled Study | |||||||||||||
Medical condition: Atrial Fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001449-16 | Sponsor Protocol Number: 39234852 | Start Date*: 2008-09-08 | |||||||||||
Sponsor Name:Andrés Ignacio Bodegas Cañas | |||||||||||||
Full Title: EFICACIA DEL IRBESARTAN EN LA FIBRILACION AURICULAR PERSISTENTE SOMETIDA A ABLACION CON RADIOFRECUENCIA POR EL SISTEMA CARTO-MERGE | |||||||||||||
Medical condition: Tratamiento de la Fibrilación Auricular mediante Ablación con radiofrecuencia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018976-25 | Sponsor Protocol Number: DRONE_L_05006 | Start Date*: 2010-08-03 | |||||||||||
Sponsor Name:sanofi-aventis Belgium | |||||||||||||
Full Title: An open label non-controlled trial to evaluate the effect of dronedarone (Multaq® 400 mg BID) on the quality of life in patiënts with a history of, or current non-permanent atrial fibrillation (AF) | |||||||||||||
Medical condition: Non permanent Atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004415-22 | Sponsor Protocol Number: 632-31 | Start Date*: 2007-02-19 | |||||||||||
Sponsor Name:Karolinska University Hospital | |||||||||||||
Full Title: Utvärdering av två oloika strategier att smärtbehandla patienter som genomgår ablationsbehandling mot hjärtrytmrubbningar i hjärtat | |||||||||||||
Medical condition: Patients undergoing catheter ablation due to arrhythmias. | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000204-33 | Sponsor Protocol Number: 01 | Start Date*: 2006-12-29 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE DI CIRCOLO A.O. DI RILIEVO REGIONALE | |||||||||||||
Full Title: REPEATED I.V. BOLUSES FLECAINIDE FOR ACUTE ATRIAL FIBRILLATION TERMINATION A SINGLE BLIND RANDOMIZED REGIMEN CONTROLLED TRIAL. | |||||||||||||
Medical condition: ATRIAL FIBRILLATION | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002888-24 | Sponsor Protocol Number: CP-AF-1 | Start Date*: 2005-03-15 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: An open-label, multi-center trial to evaluate the feasibility and safety of short-term treatment with subcutaneously injected certoparin (8000 U anti-Xa twice daily) in patients with persistent non... | |||||||||||||
Medical condition: Atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001722-27 | Sponsor Protocol Number: D1250C00042 | Start Date*: 2007-10-11 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: Long-term treatment with the oral direct thrombin inhibitor AZD0837, compared to Vitamin-K antagonists, as stroke prevention in patients with non-valvular atrial fibrillation and one or more risk f... | |||||||||||||
Medical condition: Paroxysmal persistent or permanent non-valvular atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Suspended by CA) DK (Prematurely Ended) SE (Prematurely Ended) AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.